93 related articles for article (PubMed ID: 2480562)
1. Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins.
Dudek H; Reddy EP
Oncogene; 1989 Dec; 4(12):1489-95. PubMed ID: 2480562
[TBL] [Abstract][Full Text] [Related]
2. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
Tantravahi R; Dudek H; Patel G; Reddy EP
Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
4. Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences.
Dasgupta P; Reddy EP
Oncogene; 1989 Dec; 4(12):1419-23. PubMed ID: 2687764
[TBL] [Abstract][Full Text] [Related]
5. Characterization of alternate and truncated forms of murine c-myb proteins.
Ramsay RG; Ishii S; Nishina Y; Soe G; Gonda TJ
Oncogene Res; 1989; 4(4):259-69. PubMed ID: 2549488
[TBL] [Abstract][Full Text] [Related]
6. Identification of two translational products for c-myb.
Dudek H; Reddy EP
Oncogene; 1989 Sep; 4(9):1061-6. PubMed ID: 2674850
[TBL] [Abstract][Full Text] [Related]
7. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.
Hu YL; Ramsay RG; Kanei-Ishii C; Ishii S; Gonda TJ
Oncogene; 1991 Sep; 6(9):1549-53. PubMed ID: 1923521
[TBL] [Abstract][Full Text] [Related]
8. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
10. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
Bies J; Mukhopadhyaya R; Pierce J; Wolff L
Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
[TBL] [Abstract][Full Text] [Related]
11. Structure and mechanism of activation of the myb oncogene.
Rosson D; Reddy EP
Gene Amplif Anal; 1986; 4():99-108. PubMed ID: 3333363
[TBL] [Abstract][Full Text] [Related]
12. The myb oncogene.
Lipsick JS; Baluda MA
Gene Amplif Anal; 1986; 4():73-98. PubMed ID: 3333362
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of the human c-myb gene.
Westin EH; Gorse KM; Clarke MF
Oncogene; 1990 Aug; 5(8):1117-24. PubMed ID: 2202948
[TBL] [Abstract][Full Text] [Related]
14. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
Mountz JD; Steinberg AD
J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
[TBL] [Abstract][Full Text] [Related]
15. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.
Mukhopadhyaya R; Wolff L
J Virol; 1992 Oct; 66(10):6035-44. PubMed ID: 1527851
[TBL] [Abstract][Full Text] [Related]
16. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
Bies J; Wolff L
Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
[TBL] [Abstract][Full Text] [Related]
18. Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.
Press RD; Wisner TW; Ewert DL
Oncogene; 1995 Aug; 11(3):525-35. PubMed ID: 7630637
[TBL] [Abstract][Full Text] [Related]
19. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
20. Detection of proteins that bind to the leucine zipper motif of c-Myb.
Favier D; Gonda TJ
Oncogene; 1994 Jan; 9(1):305-11. PubMed ID: 8302594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
